Booster doses are efficient at mounting strong T-cell immune responses in people living with HIV
In a peer-reviewed paper published in Viruses, a CITF-funded study led by Dr Mohammad-Ali Jenabian (Université du Québec à Montréal, UQAM), along with Dr. Aslam Anis (University of British Columbia) found that a third dose of COVID-19 vaccines induced robust cellular immune responses in people living with HIV that are comparable to what is observed in individuals without HIV.